what-to-know-about
What to Know About FemBloom Compound
FemBloom Compound is a compounded preparation from Voshell's Pharmacy. This page provides educational information about its ingredients, use, and prescription requirements.
Not medical advice. Speak with a healthcare professional before using any medication.
Reviewed by:
D. Goren
Head of Content
Updated Nov, 30
Not sure what’s worth trying?
At Voshell’s Pharmacy, we believe in honest guidance — not hype. Visit us in-store or reach out to speak with a pharmacist who knows you and your health.
Contact UsWhat Is FemBloom Compound
DISCLOSURE: Voshell's Pharmacy is a licensed compounding pharmacy that prepares and sells compounded medications by prescription. As a provider of competing products, our perspective may be influenced by our professional and commercial interests.
FemBloom Compound is the name Voshell's Pharmacy uses for compounded preparations that may include estradiol, micronized progesterone, and other hormone-related active pharmaceutical ingredients, prepared in response to a valid prescription from a qualified prescriber. Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing and are prepared by a licensed pharmacist only in response to a valid prescription for an individual patient.
What it includes
- Purpose: According to NAMS, hormone therapy may be appropriate for relieving menopausal symptoms such as hot flashes, vaginal dryness, and sleep or mood changes when standard commercial products are not suitable for a particular patient. A qualified prescriber should determine appropriateness.
- Compounding: Compounded preparations may allow dose, combination, and delivery-base customization — which may be relevant for documented allergies, commercial product shortages, or specific dosing requirements. Quality depends on use of pharmacies audited by state boards or meeting USP standards.
- FDA boxed warnings: According to the FDA-approved prescribing information for systemic estrogens, products in this class carry boxed warnings regarding endometrial cancer (in unopposed-estrogen use), cardiovascular events (stroke, deep vein thrombosis, pulmonary embolism), breast cancer, and probable dementia in postmenopausal women age 65 and older. Compounded preparations are not reviewed by FDA, but the same labeled risks for the underlying hormones apply.
Safety considerations
- Monitoring and safety: According to the Endocrine Society, use of hormone therapy requires clinical follow-up, periodic laboratory monitoring, and individualized assessment of risks and potential benefits. These decisions should be made with a qualified prescriber.
- Quality assurance: Patients should request a clear ingredient list and written instructions from the dispensing pharmacy and confirm the pharmacy operates under applicable state board and USP oversight standards.
Compounded hormone preparations are not reviewed by FDA for safety or effectiveness before dispensing. They are prepared by a licensed pharmacist only in response to a valid prescription for an individual patient. Commercially available hormone therapy options should be considered first when they meet patient needs. Clinical decisions about hormone therapy should be made with a qualified prescriber.
Key Product Features
Estradiol and Compounded Estrogen Preparations
- According to the NAMS 2022 Hormone Therapy Position Statement, estradiol and other estrogen compounds are involved in the physiological regulation of vasomotor symptoms, genitourinary tissue maintenance, and bone turnover in women during menopause. Inclusion of estradiol in a compounded preparation does not establish clinical benefit for any disease, condition, or patient outcome and requires individualized assessment by a qualified prescriber.
Progesterone in Compounded Formulations
- According to the Endocrine Society Clinical Practice Guideline on Menopause, progesterone plays a role in endometrial protection when estrogen therapy is used in women with an intact uterus, and micronized progesterone has been studied for its effects on sleep and mood in perimenopausal and postmenopausal patients. Inclusion of progesterone in a compounded preparation does not establish clinical benefit for any disease, condition, or patient outcome and should be evaluated by a qualified prescriber.
Delivery Base and Formulation Variables
- According to the USP Compounding Standards and the PCAB accreditation framework, the delivery base of a compounded preparation — such as cream, gel, troche, or capsule — is involved in determining the absorption profile and tolerability characteristics of the active ingredient. Selection of the appropriate base for a compounded hormone preparation does not establish clinical benefit for any disease, condition, or patient outcome and should be determined by a qualified prescriber in coordination with the dispensing pharmacy.
Compounding Pharmacy Quality and Oversight
- According to the FDA guidance on pharmacy compounding and USP Chapter <795>/<797> standards, compounding quality controls — including ingredient sourcing, sterility testing, and beyond-use dating — play a role in the safety profile of compounded preparations. Compliance with applicable state board requirements and voluntary accreditation programs does not establish clinical benefit for any disease, condition, or patient outcome; patients should confirm quality standards with the dispensing pharmacy.
Contact Us for a Personalized Care Plan
Have questions about compounding? Contact Voshell's Pharmacy — we prepare patient-specific medications pursuant to valid prescriptions from your licensed prescriber.
Do You Need Prescription for FemBloom Compound
Do You Need a Prescription for FemBloom Compound?
Whether a prescription is required for FemBloom Compound depends on the active ingredients it contains. If the formulation includes estradiol, progesterone, testosterone, or other regulated active pharmaceutical ingredients, a prescription is legally required in the United States. Compounded preparations containing these hormones are not reviewed by FDA for safety or efficacy prior to dispensing, and they are prepared by a licensed pharmacist only upon receipt of a valid clinician's order for an individual patient.
- Check the label and ingredient list: Look for active ingredient names such as estradiol, progesterone, or testosterone. Any of these require a valid prescription from a licensed prescriber.
- Speak with your prescriber: A qualified prescriber may assess your symptoms, relevant laboratory values, and individual risk factors before issuing a prescription and recommending a monitoring plan.
- Compounded preparations defined: Compounded hormone preparations are not reviewed by FDA for safety or efficacy prior to dispensing. They are individualized formulations prepared by a licensed pharmacist in response to a valid prescription. Patients should use pharmacies that meet applicable state board and quality standards.
- Consult a qualified prescriber: Decisions about hormone therapy, including compounded formulations, should be made in consultation with a qualified prescriber who can evaluate whether a compounded option is appropriate given commercially available alternatives.
Our Compounded HRT
Pure Bloom
Take one capsule twice daily or as directed by your healthcare practitioner.
23.90
In Stock (Ships in 1-2 Business Days)
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Explore Our Treatment
Pure Bloom
Discover detailed information about Pure Bloom, including its uses, benefits, ingredients, and how this medicine supports wellness and relief.
